Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.
Journal
Journal of cancer research and therapeutics
ISSN: 1998-4138
Titre abrégé: J Cancer Res Ther
Pays: India
ID NLM: 101249598
Informations de publication
Date de publication:
01 Jan 2024
01 Jan 2024
Historique:
received:
07
02
2022
accepted:
17
09
2022
medline:
30
3
2024
pubmed:
30
3
2024
entrez:
30
3
2024
Statut:
ppublish
Résumé
Cytochrome P450 (CYP) comprises a group of phase-I metabolizing enzymes that are important in xenobiotics metabolism. Genetic polymorphism of CYPs has been comprehensively studied for their association with a range of diseases. In this study, we assessed single-nucleotide polymorphism (SNP) of CYP1A, CYP1B, CYP2B, and CYP2C and their role in gastrointestinal (GI) cancer susceptibility in the rural population of Maharashtra. In this hospital-based case-control study, the association of polymorphism of CYP genes was studied by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The study subjects included 200 clinically confirmed GI cancer patients and equal number of healthy controls. Odds ratio (OR) with 95% confidence interval (CI) and P value were evaluated to find out the level of association, where P ≤ 0.005 was considered statistically significant. After the analysis of CYP1A1*2A (rs4646903), CYP1B1*3 (rs1059836), CYP2B6*5 (rs3211371), CYP2C8*2 (rs11572103), CYP2C9*2 (rs1799853), and CYP2C9*3 (rs1057910), we noticed that variant (T) allele of CYP2B6*5 possessed significantly elevated risk (OR = 4.43; 95% CI: 2.20-8.90; P < 0.0001) of GI cancer in studied population. The genotypic distribution of G/C heterozygote allele of CYP1B1*3 (OR = 0.19, 95% CI = 0.12-0.32; P < 0.0001) and homozygous variant C/C allele (OR = 0.24, 95% CI = 0.13-0.45; P < 0.0001) showed a negative association with the development of GI cancer. The findings from this study supported that polymorphism of CYP2B6*5gene may be involved in the development of GI cancer. However, other SNPs of CYP1A, CYP1B, and CYP2C genes did not signify the risk for GI cancer in the studied population of rural Maharashtra.
Sections du résumé
BACKGROUND
BACKGROUND
Cytochrome P450 (CYP) comprises a group of phase-I metabolizing enzymes that are important in xenobiotics metabolism. Genetic polymorphism of CYPs has been comprehensively studied for their association with a range of diseases. In this study, we assessed single-nucleotide polymorphism (SNP) of CYP1A, CYP1B, CYP2B, and CYP2C and their role in gastrointestinal (GI) cancer susceptibility in the rural population of Maharashtra.
MATERIALS AND METHODS
METHODS
In this hospital-based case-control study, the association of polymorphism of CYP genes was studied by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The study subjects included 200 clinically confirmed GI cancer patients and equal number of healthy controls. Odds ratio (OR) with 95% confidence interval (CI) and P value were evaluated to find out the level of association, where P ≤ 0.005 was considered statistically significant.
RESULTS
RESULTS
After the analysis of CYP1A1*2A (rs4646903), CYP1B1*3 (rs1059836), CYP2B6*5 (rs3211371), CYP2C8*2 (rs11572103), CYP2C9*2 (rs1799853), and CYP2C9*3 (rs1057910), we noticed that variant (T) allele of CYP2B6*5 possessed significantly elevated risk (OR = 4.43; 95% CI: 2.20-8.90; P < 0.0001) of GI cancer in studied population. The genotypic distribution of G/C heterozygote allele of CYP1B1*3 (OR = 0.19, 95% CI = 0.12-0.32; P < 0.0001) and homozygous variant C/C allele (OR = 0.24, 95% CI = 0.13-0.45; P < 0.0001) showed a negative association with the development of GI cancer.
CONCLUSION
CONCLUSIONS
The findings from this study supported that polymorphism of CYP2B6*5gene may be involved in the development of GI cancer. However, other SNPs of CYP1A, CYP1B, and CYP2C genes did not signify the risk for GI cancer in the studied population of rural Maharashtra.
Identifiants
pubmed: 38554324
doi: 10.4103/jcrt.jcrt_294_22
pii: 01363817-202420010-00034
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
216-223Informations de copyright
Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.
Références
GLOBOCAN 2020:New global cancer data. Global Cancer Burden 2020. Available from https://www.uicc.org/news/globocan-2020-new-global-cancer-data [Cited on 2020 Dec 17].
Megraud F, Bessede E, Varon C. Helicobacter pylori infection and gastric carcinoma. Clin Microbiol Infect 2015;21:984–90.
Jain VS, Kawale D, Jain SM, Waghmare C, Pemmaraju G. Various addiction patterns, dietary habits, associated medical problems, and socioeconomic status in gastrointestinal malignancies:A prospective study in rural area of Maharashtra. J Cancer Res Ther 2019;15:104–7.
Bag A, Jyala NS, Bag N. Cytochrome P4501A1 genetic polymorphisms as cancer biomarkers. Ind J Cancer 2015;52:479–89.
Alzahrani AM, Rajendran P. The multifarious link between cytochrome P450s and cancer. Oxid Med Cel Longev 2020;2020:3028387. doi:10.1155/2020/3028387.
doi: 10.1155/2020/3028387
Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism:Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013;138:103–41.
Elfaki I, Mir R, Almutairi FM, Duhier FMA. Cytochrome P450:Polymorphisms and roles in cancer, diabetes and atherosclerosis. Asian Pac J Cancer Prev 2018;19:2057–70.
Wang H, Zhang Z, Han S, Lu Y, Feng F, Yuan J. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility:a meta-analysis from 19 case-control studies. BMC Cancer 2012;12:528. doi:10.1186/1471-2407-12-528.
doi: 10.1186/1471-2407-12-528
Naif HM, Al-Obaide MAI, Hassani HH, Hamdan AS, Kalaf ZS. Association of Cytochrome CYP1A1 gene polymorphisms and tobacco smoking with the risk of breast cancer in women from Iraq. Front Public Health 2018;6:96. doi:10.3389/fpubh.2018.00096.
doi: 10.3389/fpubh.2018.00096
Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer 2009;40:26–32.
He XF, Wei J, Liu ZZ, Xie JJ, Wang W, Du YP, et al. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer Risk:A meta-analysis. PLoS One 2014;9:e100487.
Balaji L, Singh KB, Bhaskar LV. CYP1A1 genotypes and haplotypes and risk of oral cancer:A case-control study in South Indians. Genet Mol Biol 2012;35:407–12.
Ding B, Sun W, Han S, Cai Y, Ren M, Shen Y. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk:A systematic review and meta-analysis. Medicine 2018;97:e0210. doi:10.1097/MD.0000000000010210.
doi: 10.1097/MD.0000000000010210
Zhu X, Wang Z, He J, Wang W, Xue W, Wang Y, et al. Associations between CYP1A1 rs1048943 A>G and rs4646903 T>C genetic variations and colorectal cancer risk:Proof from 26 case-control studies. Oncotarget 2016;7:51365–74.
Darazy M, Balbaa M, Mugharbil A, Saeed H, Sidani H, Abdel-Razzak Z. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese. Genet Test Mol Biomark 2011;15:423–9.
Ghoshal U, Tripathi S, Kumar S, Mittal B, Chourasia D, Kumari N, et al. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 2014;17:226–34.
Guo R, Guo X. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumor Biol 2012;33:1125–32.
Oztas E, Ozhan G, Dally AK. The effect of the CYP1A1*2A allele on colorectal cancer susceptibility in British population. Genet Test Mol Biomark 2016;20:475–7.
Watanabe J, Shimada T, Gillam EMJ, Ikuta T, Suemasu K, Higashi Y, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenet Genomics 2000;10:25–33.
Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer:A meta-analysis. PLoS ONE 2013;8:e68634.
Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, et al. CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2014;134:426–30.
Alazhary NM, Shafik RE, Shafik HE, Kamel MM. Prognostic value of a CYP2B6 gene polymorphism in patients with acute myeloid leukemia. Asian Pac J Cancer Prev 2015;16:4583–7.
Essa ES, AlHassanin SA, Radwan WM, Hagag MG. Evaluation of CYP2B6 G15631T polymorphism as a risk factor for development of chronic myeloid leukemia. Breast Cancer Res 2020;33:926–9.
Ladero JM, Agundez JAG, Martinez C, Amo G, Ayuso P, García-Martín E. Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk. Front Genet 2012;3:278. doi:10.3389/fgene. 2012.00278.
doi: 10.3389/fgene.
Liang S, Hu J, Cao W, Cai S. Correction meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk. PLoS One 2013;8. doi:10.1371/annotation/405a8737-be71-4ff1-8755-a3ccf11cb67f.
doi: 10.1371/annotation/405a8737-be71-4ff1-8755-a3ccf11cb67f
Zhou B, Song Z, Qian M, Li L, Gong J, Zou S. Functional polymorphisms in the CYP2C19 gene contribute to digestive asystem cancer risk:Evidence from 11,042 Subjects. PLoS One 2013;8:e66865. doi:10.1371/journal.pone.0066865.
doi: 10.1371/journal.pone.0066865
Mathur P, Satishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer statistics, 2020:Report from National Cancer Registry Programme, India. JCO Glob Oncol 2020;6:1063–75.
Yuan X, Zhou G, Zhai Y, Xie W, Cui Y, Cao J, et al. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:3621–7.
Seredina TA, Goreva OB, Talaban VO, Grishanova AY, Lyakhovich VV. Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients. BMC Med Genet 2012;13:45–51.
Agundez JAG. Cytochrome P450 gene polymorphism and Cancer. Curr Drug Metab 2004;5:211–24.
Umamaheswaran G, Dhakchinamoorthi KK, Chandrasekaran A. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes &drug transporters-A review with Indian perspective. Ind J Med Res 2014;139:27–65.
Mahdi F, Raza ST, Rizvi S, Abbas S, Karoli R. Distribution of genetic polymorphisms in drug metabolizing gene cytochrome P450 (CYP2C8*3 and CYP2C9*2) in a North Indian type 2 diabetes population. Expl Res Hypot Med 2016;1:42–6.
Luo B, Yan D, Yan H, Yuan J. Cytochrome P450:Implications for human breast cancer (Review). Oncol Lett 2021;22:548.
Ezzeldin N, El-Lebedy D, Darwish A, El-Bastawisy A, Hassan M, El-Aziz A, et al. Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer. Genes. Environ 2017;39. doi:10.1186/s41021-016-0066-4.
doi: 10.1186/s41021-016-0066-4
Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 2010;62:734–42.
Li Y, Tan SQ, Ma QH, Li L, Huang ZY, Wang Y, et al. CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women. Tumor Biol 2013;34:3561–7.
Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, et al. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumor Biol 2014;35:10223–30.
Shah IA, Mehta P, Lone MM, Dar NA. Leu432Val Polymorphism of CYP1B1 is not associated with squamous cell carcinoma of esophagus-A case-control study from Kashmir, India. Asian Pac J Cancer Prev 2015;16:5337–41.
Liang S, Hu J, Cao W, Cai S. Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk. PLoS One 2012;7:e49134. doi:10.1371/journal.pone.0049134.
doi: 10.1371/journal.pone.0049134
Ahmed S, Khan S, Naqvi SU, Janjua K, Zulfiqar Z, Ahmedah H. Lack of association of CYP2C9 genetic polymorphism with oral squamous cell carcinoma. Research Square 2020:PPR167893. doi:10.21203/rs. 3.rs-27686/v1.
doi: 10.21203/rs.
Katiyar T, Maurya SS, Hasan F, Singh AP, Khan AJ, Hadi R, et al. Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk. Environ Mol Mutagen 2017;58:443–50.